Stock APVO APTEVO THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Aptevo Therapeutics Inc.

Equities

APVO

US03835L3069

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.3129 USD -5.47% Intraday chart for Aptevo Therapeutics Inc. +7.19% -96.07%
Jul. 01 Aptevo Therapeutics Inc. announced that it has received $2.75 million in funding CI
Jun. 28 Aptevo Shares Decline After Pricing of $2.8 Million Stock Offering MT

Evolution of the average Target Price on Aptevo Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

ef0b923.5hqPbQX8YW79n-plyJXE58T88VWqqgye6etSLWVjTao.tii2GFS7BS2iqKcSn9SllPGuuTP1mFjJp9oNXj1SF9CedcQ5TY4wCKnHhQ~ac15c18077b76c7904924004ef64b48d

Analyst Recommendations on Aptevo Therapeutics Inc.

Piper Sandler Adjusts Price Target on Aptevo Therapeutics to $20 From $69, Reiterates Overweight Rating MT
Roth Capital Adjusts Aptevo Therapeutics' Price Target to $36 From $50, Reiterates Buy Rating MT
APTEVO THERAPEUTICS : Roth Capital Adjusts Aptevo Therapeutics PT to $50 From $64, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.3129 USD
Average target price
748 USD
Spread / Average Target
+238,953.72%
High Price Target
748 USD
Spread / Highest target
+238,953.72%
Low Price Target
748 USD
Spread / Lowest Target
+238,953.72%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Aptevo Therapeutics Inc.

Piper Sandler
Roth Capital Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. APVO Stock
  4. Consensus Aptevo Therapeutics Inc.